Showing results (11-20 of 93) with videos related to
Sort By:
Pageof 10
Trends in Immunology|August 16, 2025
Molecular mimicry as a driver of T cell-mediated tumour immunityJamie Rossjohn, Luigi Nezi, Julianne S Walz, et al.Cancers|October 14, 2022
Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease OutcomeMaddalena Marconato, Yacine Maringer, Juliane S Walz, et al.Viruses|October 28, 2023
Long-Term Follow-Up of COVID-19 Convalescents-Immune Response Associated with Reinfection Rate and SymptomsAnna Seller, Christopher Hackenbruch, Juliane S Walz, et al.Annals of Hematology|January 4, 2020
Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma-a long-term follow-up single center experienceMalte Roerden, Martin Sökler, Lothar Kanz, et al.Cancers|June 2, 2021
Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose ChemotherapyMalte Roerden, Stefan Wirths, Martin Sökler, et al.Wellcome Open Research|May 27, 2024
Reanalysis of Immunopeptidomics Datasets Provides Mechanistic Insight into TAPBPR-Mediated Peptide Editing on HLA-A, -B and -C MoleculesArwen F Altenburg, Jack L Morley, Jens Bauer, et al.Vox Sanguinis|June 9, 2005
Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro qualityJ Ringwald, S Walz, R Zimmermann, et al.Viruses|March 30, 2023
Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID SyndromeChristopher Hackenbruch, Yacine Maringer, Christian M Tegeler, et al.Frontiers in Immunology|August 7, 2023
Immunoprecipitation methods impact the peptide repertoire in immunopeptidomicsMarcel Wacker, Jens Bauer, Laura Wessling, et al.Der Internist|May 29, 2020
[Tumor vaccines-therapeutic vaccination against cancer]H-G Rammensee, M W Löffler, J S Walz, et al.Pageof 10